Evidence map›Paper›PMID 42679007›Full record

Trial reportPLoS medicine2026

Effect of a person-centered care intervention on return and sustained reengagement after treatment interruptions from HIV care in Zambia: A post-hoc analysis of a stepped-wedged cluster randomized trial.

Aaloke Mody, Kombatende Sikombe, Sandra Simbeza, Njekwa Mukamba, Laura K Beres, Jake M Pry, Anjali Sharma, Jacob Mutale, Alida Zulu Dube, Musunge Mulabe and 8 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Aaloke ModyDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0003-3787-365X
Kombatende SikombeCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-8187-8661
Sandra SimbezaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-0150-3369
Njekwa MukambaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-5757-6858
Laura K BeresDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0002-4731-7828
Jake M PryCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0001-6312-4420
Anjali SharmaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-8189-0732
Jacob MutaleCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-8914-0645
Alida Zulu DubeCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Musunge MulabeCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0009-0001-9722-4558
Lloyd MulengaZambian Ministry of Health, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-1044-4209
Suilanji SivileZambian Ministry of Health, Lusaka, Zambia.ORCID https://orcid.org/0009-0005-3072-475X
April RatliffDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0003-4473-2951
Charles W GossDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0003-2682-7316
Charles B HolmesCenter for Innovation in Global Health, Georgetown University, Washington, D.C., United States of America.ORCID https://orcid.org/0000-0002-7924-6761
Carolyn Bolton MooreCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0001-9103-7746
Izukanji SikazweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-3898-2607
Elvin H GengDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0002-0825-1424

Funding

Sequential Strategies to Reach and Reengage Individuals after Lapses from HIV Care in ZambiaR01MH135819 · NIMH · WASHINGTON UNIVERSITY · PI Aaloke Mody · 2024 to 2026
$1.9M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care after Treatment Lapses in ZambiaR34MH129219 · NIMH · WASHINGTON UNIVERSITY · PI MODY, AALOKE · 2022 to 2024
$605k
Bill & Melinda Gates Foundation INV-010563NIAID NIH HHS K24 AI134413NIMH NIH HHS R01 MH135819NIMH NIH HHS R34 MH129219
6 · The paper itself

Abstract

backgroundPoor client-provider interactions lead to reinforcing cycles of treatment interruptions (TIs) from HIV care and fear of return, undermining sustained retention. We previously demonstrated a multi-component person-centered care intervention (PCC) targeting healthcare worker (HCW) behavior improved client experience and retention in HIV care. To understand mechanisms of improved retention, we evaluated the effect of the PCC intervention on return after TIs and sustained retention after return in a post-hoc analysis, hypothesizing that friendlier HCW attitudes enable successful reengagement into care. METHODS AND

findingsWe implemented the PCC intervention at 24 clinics in Zambia in a stepped-wedge, cluster randomized trial from Aug 2019 to Nov 2021. Clinics were allocated into 4 groups (8 clinics in Groups 1 and 4, and 4 each in Groups 2 and 3) and randomly assigned to crossover from control to intervention every 6 months. Under control, clinics provided routine HIV care without additional support. Afterwards, clinics received the PCC intervention targeting caring aspects of HCW behavior with 1) training and coaching on PCC practices, 2) measurement and feedback of client experience (via exit interviews), and 3) small facility-level incentives. We examined individuals living with HIV who became >30 days late to a scheduled visit (i.e., TI), categorizing intervention exposure based on the last visit prior to TI. We used electronic health records to assess the effect of the PCC intervention on 1) return to HIV care after a TI, and 2) repeat TIs among those who returned. We used multistate analytic methods to estimate crude incidence of return and repeat TIs and prevalence of being in care at 1-year. We used shared frailty Cox proportional hazards and mixed-effects Poisson models to obtain formal comparisons that accounted for the stepped-wedge design. Individuals were censored at intervention crossover or database closure. During the study period, 128,910 clients (n = 69,671 control, n = 59,239 intervention) became >30 days late (64.3% female, median age 38y [IQR 31,45], median years in care 2.5y [IQR 0.6,6.7]). The PCC intervention increased incidence of return after TI at 12-months (72.3% intervention versus 67.7% control, crude risk difference [RD] +4.6% [CI 4.1,5.2], adjusted hazard ratio [aHR] 1.16 [CI 1.12,1.20]; p < 0.001). Among returners, the intervention decreased incidence of repeat TIs (44.3% versus 55.6%, RD -11.4% [CI -12.2,-10.6], aHR 0.50 [CI 0.45,0.55]; p < 0.001) and increased the proportion in care (with or without repeat TIs) (82.7% versus 73.4%, RD +9.3% [CI 8.6,10.0], adjusted risk ratio [aRR] 1.14 [CI 1.05,1.25]; p = 0.002) at 12-months after return. Overall, the PCC intervention increased the proportion in care 12-months after a TI from 51.5% to 60.1% (RD +8.7% [CI 8.0,9.3], aRR 1.19 [CI 1.05,1.35]; p = 0.008). Effect sizes were similar in direction and magnitude in multiple sensitivity analyses with varying precision. Limitations included post-hoc analysis and those associated with stepped-wedge design.

conclusionsThe PCC intervention likely improved rates of return to care after TIs, sustained reengagement after return, and overall retention among individuals with TIs. Strategies targeting caring aspects of HCW behavior and client experience may help lower barriers to and address persistent challenges with reengagement in care.

Indexed as

Anti-HIV AgentsHIV InfectionsPatient-Centered CareAdherence InterventionsAdultFemaleHealth PersonnelHumansMaleRetention in CareTreatment InterruptionZambiaAnti-HIV Agents

Identifiers

PMID42679007
PMCPMC13533374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.